Correlation Between Redhill Biopharma and CV Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Redhill Biopharma and CV Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Redhill Biopharma and CV Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Redhill Biopharma and CV Sciences, you can compare the effects of market volatilities on Redhill Biopharma and CV Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Redhill Biopharma with a short position of CV Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Redhill Biopharma and CV Sciences.

Diversification Opportunities for Redhill Biopharma and CV Sciences

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Redhill and CVSI is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Redhill Biopharma and CV Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CV Sciences and Redhill Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Redhill Biopharma are associated (or correlated) with CV Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CV Sciences has no effect on the direction of Redhill Biopharma i.e., Redhill Biopharma and CV Sciences go up and down completely randomly.

Pair Corralation between Redhill Biopharma and CV Sciences

Given the investment horizon of 90 days Redhill Biopharma is expected to under-perform the CV Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Redhill Biopharma is 1.12 times less risky than CV Sciences. The stock trades about -0.01 of its potential returns per unit of risk. The CV Sciences is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  3.00  in CV Sciences on August 27, 2024 and sell it today you would earn a total of  1.00  from holding CV Sciences or generate 33.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Redhill Biopharma  vs.  CV Sciences

 Performance 
       Timeline  
Redhill Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Redhill Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical indicators, Redhill Biopharma is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.
CV Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CV Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, CV Sciences is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Redhill Biopharma and CV Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Redhill Biopharma and CV Sciences

The main advantage of trading using opposite Redhill Biopharma and CV Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Redhill Biopharma position performs unexpectedly, CV Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CV Sciences will offset losses from the drop in CV Sciences' long position.
The idea behind Redhill Biopharma and CV Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.